|
Identification of FAS Gene Mutations in Adult T-Cell Leukemia/Lymphoma (ATL) and HTLV-I Associated Myelopathy (HAM/TSP). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Merck Serono; Merck Sharp & Dohme; Novartis; Roche |
Consulting or Advisory Role - Merck Serono; Merck Sharp & Dohme; Novartis |
Research Funding - Novartis |
Travel, Accommodations, Expenses - Amgen |
|
|
|
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Merck; Roche; SERVIER; Sirtex Medical |
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst); Ventana Medical Systems (Inst) |
|
|
Honoraria - Roche; Sanofi |
|
|
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Merck Serono; Novartis; Ono Pharmaceutical; ONXEO |
Speakers' Bureau - Novartis |
Research Funding - Sanofi |